NAMS MENOPAUSE CERTIFICATION
MENOPAUSE SOCIETY CERTIFIED PRACTITIONER (MSCP) EXAM
QUESTIONS AND 100% VERIFIED ANSWERS WITH RATIONALES
GRADED A+
GUARANTEED PASS ON THE FIRST ATTEMPT
Question 1
A 47-year-old woman presents with irregular menses, night sweats, and difficulty
sleeping. Her FSH level is intermittently elevated. What is the most appropriate
diagnosis?
A. Primary ovarian insufficiency
B. Late reproductive stage
C. Perimenopause
D. Menopause
Correct Answer: C
Rationale:
Perimenopause is characterized by menstrual irregularity and fluctuating hormone
levels with vasomotor symptoms. Menopause is diagnosed retrospectively after 12
months of amenorrhea.
,Question 2
Which symptom is most strongly associated with estrogen deficiency during the
menopausal transition?
A. Migraine headaches
B. Vasomotor symptoms
C. Weight gain
D. Fatigue
Correct Answer: B
Rationale:
Hot flashes and night sweats are hallmark vasomotor symptoms directly related to
estrogen withdrawal affecting hypothalamic thermoregulation.
Question 3
A healthy 52-year-old woman with an intact uterus seeks treatment for bothersome
hot flashes. What is the most appropriate first-line therapy?
A. Estrogen-only therapy
B. Combined estrogen-progestogen therapy
C. SSRI therapy
D. Herbal supplementation
Correct Answer: B
Rationale:
Women with a uterus require progestogen in addition to estrogen to protect against
endometrial hyperplasia and cancer.
Question 4
Which finding represents an absolute contraindication to systemic menopausal
hormone therapy?
A. Controlled hypertension
B. History of venous thromboembolism
,C. Migraine without aura
D. Obesity
Correct Answer: B
Rationale:
A history of venous thromboembolism is a contraindication due to increased
clotting risk associated with systemic estrogen therapy.
Question 5
Which route of estrogen administration is associated with the lowest risk of venous
thromboembolism?
A. Oral estrogen
B. Transdermal estrogen
C. Vaginal estrogen ring
D. Injectable estrogen
Correct Answer: B
Rationale:
Transdermal estrogen bypasses hepatic first-pass metabolism, resulting in less
impact on clotting factors.
Question 6
A 55-year-old woman reports dyspareunia and vaginal dryness but has no
vasomotor symptoms. What is the preferred treatment?
A. Systemic estrogen therapy
B. Combined estrogen-progestogen therapy
C. Vaginal estrogen therapy
D. SSRI therapy
Correct Answer: C
, Rationale:
Local vaginal estrogen is first-line for genitourinary syndrome of menopause
without systemic symptoms.
Question 7
Which nonhormonal medication has the strongest evidence for reducing hot
flashes?
A. Gabapentin
B. Clonidine
C. Bupropion
D. Propranolol
Correct Answer: A
Rationale:
Gabapentin has demonstrated significant efficacy in reducing vasomotor
symptoms, particularly nocturnal symptoms.
Question 8
What is the primary mechanism by which SSRIs reduce vasomotor symptoms?
A. Estrogen receptor modulation
B. Improved sleep quality
C. Thermoregulatory stabilization via serotonin pathways
D. Reduced cortisol production
Correct Answer: C
Rationale:
SSRIs influence hypothalamic serotonin pathways involved in temperature
regulation.
MENOPAUSE SOCIETY CERTIFIED PRACTITIONER (MSCP) EXAM
QUESTIONS AND 100% VERIFIED ANSWERS WITH RATIONALES
GRADED A+
GUARANTEED PASS ON THE FIRST ATTEMPT
Question 1
A 47-year-old woman presents with irregular menses, night sweats, and difficulty
sleeping. Her FSH level is intermittently elevated. What is the most appropriate
diagnosis?
A. Primary ovarian insufficiency
B. Late reproductive stage
C. Perimenopause
D. Menopause
Correct Answer: C
Rationale:
Perimenopause is characterized by menstrual irregularity and fluctuating hormone
levels with vasomotor symptoms. Menopause is diagnosed retrospectively after 12
months of amenorrhea.
,Question 2
Which symptom is most strongly associated with estrogen deficiency during the
menopausal transition?
A. Migraine headaches
B. Vasomotor symptoms
C. Weight gain
D. Fatigue
Correct Answer: B
Rationale:
Hot flashes and night sweats are hallmark vasomotor symptoms directly related to
estrogen withdrawal affecting hypothalamic thermoregulation.
Question 3
A healthy 52-year-old woman with an intact uterus seeks treatment for bothersome
hot flashes. What is the most appropriate first-line therapy?
A. Estrogen-only therapy
B. Combined estrogen-progestogen therapy
C. SSRI therapy
D. Herbal supplementation
Correct Answer: B
Rationale:
Women with a uterus require progestogen in addition to estrogen to protect against
endometrial hyperplasia and cancer.
Question 4
Which finding represents an absolute contraindication to systemic menopausal
hormone therapy?
A. Controlled hypertension
B. History of venous thromboembolism
,C. Migraine without aura
D. Obesity
Correct Answer: B
Rationale:
A history of venous thromboembolism is a contraindication due to increased
clotting risk associated with systemic estrogen therapy.
Question 5
Which route of estrogen administration is associated with the lowest risk of venous
thromboembolism?
A. Oral estrogen
B. Transdermal estrogen
C. Vaginal estrogen ring
D. Injectable estrogen
Correct Answer: B
Rationale:
Transdermal estrogen bypasses hepatic first-pass metabolism, resulting in less
impact on clotting factors.
Question 6
A 55-year-old woman reports dyspareunia and vaginal dryness but has no
vasomotor symptoms. What is the preferred treatment?
A. Systemic estrogen therapy
B. Combined estrogen-progestogen therapy
C. Vaginal estrogen therapy
D. SSRI therapy
Correct Answer: C
, Rationale:
Local vaginal estrogen is first-line for genitourinary syndrome of menopause
without systemic symptoms.
Question 7
Which nonhormonal medication has the strongest evidence for reducing hot
flashes?
A. Gabapentin
B. Clonidine
C. Bupropion
D. Propranolol
Correct Answer: A
Rationale:
Gabapentin has demonstrated significant efficacy in reducing vasomotor
symptoms, particularly nocturnal symptoms.
Question 8
What is the primary mechanism by which SSRIs reduce vasomotor symptoms?
A. Estrogen receptor modulation
B. Improved sleep quality
C. Thermoregulatory stabilization via serotonin pathways
D. Reduced cortisol production
Correct Answer: C
Rationale:
SSRIs influence hypothalamic serotonin pathways involved in temperature
regulation.
